Associated Papers
CYP2B6 haplotype and biological factors responsible for hepatotoxicity in HIV-infected patients receiving efavirenz-based antiretroviral therapy.
Manosuthi W et al.
International Journal of Antimicrobial Agents, 2014
Impact of pharmacogenetic markers of CYP2B6, clinical factors, and drug-drug interaction on efavirenz concentrations in HIV/tuberculosis-coinfected patients.
Manosuthi W et al.
Antimicrobial Agents and Chemotherapy, 2013
Select a paper to view details